Liang Xinjun, Da Mingxu, Zhuang Zhiqiang, Wu Weiguang, Wu Zhuang, Wu Yanfeng, Shen Huiyong
Department of Orthopaedics, Sun-Yat-Sen Memorial Hospital, Sun-Yat-Sen University, 107 West Yanjiang Road, Guangzhou 510120, PR China.
Cell Biol Int. 2009 Jan;33(1):119-24. doi: 10.1016/j.cellbi.2008.10.013. Epub 2008 Nov 1.
Osteosarcoma is the most frequent primary malignant tumor of the skeleton and occurs mainly in children and adolescent. The prognosis of osteosarcoma is very poor due to its aggressive and no effective treatment. This study is the first to investigate the anti-cancer effects of antisense pEGFP-C1-Survivin on human osteosarcoma cells. It was shown in our results that Survivin blockaded could significantly induce apoptosis and inhibit the invasive of osteosarcoma cells line MG-63. The effects were probably produced by the decreased expression of Survivin induced by antisense pEGFP-C1-Survivin which was examined by RT-PCR and western blotting. All these suggested that Survivin should be very important in the development of osteosarcoma and Survivin blockaded by using antisense pEGFP-C1-Survivin could markedly inhibit the proliferation and invasion of osteosarcoma cells line MG-63, partially reversed their malignant phenotype. Targeting Survivin might be a promising option in the treatment of osteosarcoma.
骨肉瘤是骨骼中最常见的原发性恶性肿瘤,主要发生于儿童和青少年。由于骨肉瘤具有侵袭性且缺乏有效的治疗方法,其预后非常差。本研究首次探讨了反义pEGFP-C1-Survivin对人骨肉瘤细胞的抗癌作用。我们的结果表明,Survivin阻断可显著诱导凋亡并抑制骨肉瘤细胞系MG-63的侵袭。这些作用可能是由反义pEGFP-C1-Survivin诱导的Survivin表达降低所致,通过RT-PCR和蛋白质印迹法进行了检测。所有这些表明,Survivin在骨肉瘤的发生发展中非常重要,利用反义pEGFP-C1-Survivin阻断Survivin可显著抑制骨肉瘤细胞系MG-63的增殖和侵袭,部分逆转其恶性表型。靶向Survivin可能是治疗骨肉瘤的一个有前景的选择。